Skip to main content

Articles

Practice Management
Key Trends in Healthcare for 2020 and Beyond
F. Randy Vogenberg, PhD; John Santilli, MBA
Read More
ASH 2019 - Chronic Lymphocytic Leukemia
Ibrutinib + Rituximab versus FCR in Younger Patients with CLL: Extended Follow-Up of E1912 Trial
Read More
ASH 2019 - Chronic Lymphocytic Leukemia
Combined Ibrutinib and Venetoclax for First-Line Treatment of Patients with Chronic Lymphocytic Leukemia
Read More
ASH 2019 - Chronic Lymphocytic Leukemia
ELEVATE TN: Results of a Phase 3 Study of Acalabrutinib in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia
Read More
ASH 2019 - Chronic Lymphocytic Leukemia
Ibrutinib + Venetoclax for First-Line Treatment of CLL: Results from the MRD Cohort of the Phase 2 CAPTIVATE Study
Read More
ASH 2019 - Chronic Lymphocytic Leukemia
Polatuzumab Vedotin + Obinutuzumab + Lenalidomide in Patients with Relapsed/Refractory Follicular Lymphoma
Read More
FDA Approvals, In the News
November 11, 2019 — Oncology News & Updates
Read More
In the News, Leukemia, Oncology
November 4, 2019 — Oncology News & Updates
Read More
FDA Approvals, In the News
October 28, 2019 – Oncology News & Updates
Read More
Breast Cancer, FDA Approvals, In the News, Multiple Myeloma, Pediatric Cancer, Oncology
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Read More
Page 44 of 244
Results 431 - 440 of 2436